Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000311035 | SCV000371264 | uncertain significance | Meacham syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000350607 | SCV000371265 | uncertain significance | Nephroblastoma | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000268186 | SCV000371266 | uncertain significance | 11p partial monosomy syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000316345 | SCV000371267 | uncertain significance | Nephrotic syndrome, type 4 | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000350607 | SCV000371276 | uncertain significance | Nephroblastoma | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000268186 | SCV000371277 | uncertain significance | 11p partial monosomy syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000311035 | SCV000371278 | uncertain significance | Meacham syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000316345 | SCV000371279 | uncertain significance | Nephrotic syndrome, type 4 | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004693032 | SCV005191240 | uncertain significance | not provided | criteria provided, single submitter | not provided |